Spring has nearly sprung and round two of the Inflation Reduction Act (IRA)’s negotiation period has begun. | All of the ...

The Cigna Group Completes Sale of Medicare Businesses to HCSC The transaction is not expected to disrupt coverage or s ...

All pharmaceutical manufacturers, including Novo Nordisk (NYSE:NVO) and Teva Pharmaceuticals, have agreed to participate in ...

Drugmakers are urging the Trump administration and European Union officials to exclude medical goods from expanding tariff ...

Dr. Mehmet Oz, the celebrity physician nominated by President Donald Trump to oversee the government's Medicare and Medicaid ...

Alnylam's Amvuttra enters ATTR-CM drug race, and Expedition Therapeutics seeks to bring Chinese drugs to the U.S.

(Reuters) - Manufacturers of the 10 prescription drugs subject to price negotiations for the U.S. Medicare program have signed on... By Sruthi Shankar, Siddarth S and Shristi Achar A (Reuters ...

Novo Nordisk sees the obesity drug market expanding ... using Wegovy in a program that negotiates lower prices for Medicare in 2027. This could make Wegovy and similar drugs more affordable ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

How GLP-1 drugs, regulatory concerns, and more factors are shaping the sector. Plus, 3 undervalued healthcare stocks.

Drugmakers are urging the Trump administration and European Union officials to exempt medical goods from widening tariff wars, hoping to avert an ...